Moderate Ovarian Stimulation Does Not Increase the Incidence of Human Embryo Chromosomal Abnormalities inin VitroFertilization Cycles
Open Access
- 1 October 2012
- journal article
- clinical trial
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 97 (10), E1987-E1994
- https://doi.org/10.1210/jc.2012-1738
Abstract
Context: A high chromosomal abnormalities rate has been observed in human embryos derived from in vitro fertilization (IVF) treatments. The real incidence in natural cycles has been poorly studied, so whether this frequency may be induced by external factors, such as use of gonadotropins for ovarian stimulation, remains unknown. Design: We conducted a prospective cohort study in a University-affiliated private infertility clinic with a comparison between unstimulated and stimulated ovarian cycles in the same women. Preimplantation genetic screening by fluorescence in situ hybridization was performed in all viable d 3 embryos. Objective: The primary objective was to compare the incidence of embryo chromosomal abnormalities in an unstimulated cycle and in an ulterior moderate ovarian stimulated cycle. Secondary outcome measures were embryo quality, blastocyst rate of biopsied embryos, number of normal blastocysts per donor, type of chromosomal abnormalities, and clinical outcome. Results: One hundred eighty-five oocyte donors were initially recruited for the unstimulated cycle, and preimplantation genetic screening could be performed in 51 of them, showing 35.3% of embryo chromosomal abnormalities. Forty-six of them later completed a stimulated cycle. The sperm donor sample was the same for both cycles. The proportion of embryos displaying abnormalities in the unstimulated cycle was 34.8% (16 of 46), whereas it was 40.6% (123 of 303) in the stimulated cycle with risk difference = 5.8 [95% confidence interval (CI) = −20.6–9.0], and relative risk = 1.17 (95% CI = 0.77–1.77) (P = 0.45). When an intrasubject comparison was made, the abnormalities rate was 34.8% (95% CI = 20.5–49.1) in the unstimulated cycle and 38.2% (95% CI = 30.5–45.8) in the stimulated cycle [risk difference = 3.4 (95% CI = −17.9–11.2); P = 0.64]. No differences were observed for embryo quality and type of chromosomal abnormalities. Conclusions: Moderate ovarian stimulation in young normo-ovulatory women does not significantly increase the embryo aneuploidies rate in in vitro fertilization-derived human embryos as compared with an unstimulated cycle. Whether these results can be extrapolated to infertile patients is still unknown.Keywords
This publication has 32 references indexed in Scilit:
- Further evidence that culture media affect perinatal outcome: findings after transfer of fresh and cryopreserved embryosHuman Reproduction, 2012
- The risk of cytogenetic abnormalities in the late first trimester of pregnancies conceived through assisted reproductionFertility and Sterility, 2011
- Impact of different patterns of sperm chromosomal abnormalities on the chromosomal constitution of preimplantation embryosFertility and Sterility, 2010
- A prospective randomized controlled trial of preimplantation genetic screening in the “good prognosis” patientFertility and Sterility, 2009
- Relationship between women's age and basal follicle-stimulating hormone levels with aneuploidy risk in in vitro fertilization treatmentFertility and Sterility, 2008
- Aneuploidy in the miscarriages of infertile women and the potential benefit of preimplanation genetic diagnosisFertility and Sterility, 2008
- Elucidating the origin of chromosomal aberrations in IVF embryos by preimplantation genetic analysisMolecular and Cellular Endocrinology, 2008
- Development of a hamster superovulation program and adverse effects of gonadotropins on microfilament formation during oocyte developmentFertility and Sterility, 2005
- Follicle-Stimulating Hormone Affects Metaphase I Chromosome Alignment and Increases Aneuploidy in Mouse Oocytes Matured in Vitro1Biology of Reproduction, 2005
- Genotoxic and embryotoxic effects of gonadotropin-hyperstimulated ovulation of murine oocytes, preimplantation embryos, and term fetusesReproductive Toxicology, 1992